Locally advanced non-metastatic pancreatic cancer--can we do more?

Locally advanced non-metastatic pancreatic cancer--can we do more?

Bibliographic Details
Main Authors:	Hawkins, M, Tait, D
Format:	Journal article
Language:	English
Published:	2008

Similar Items

Dose escalation for locally advanced pancreatic cancer: How high can we go?
by: Lauren E. Colbert, MD, et al.
Published: (2018-10-01)

Pancreatic cancer within a UK cancer network with special emphasis on locally advanced non-metastatic pancreatic cancer.
by: Mukherjee, S, et al.
Published: (2008)

Metastatic Pancreatic Cancer: Where Are We?
by: Abraham Hernández-Blanquisett, et al.
Published: (2024-01-01)

We Can Do More
by: Howard Adelman
Published: (1992-09-01)

Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
by: Borghesi, S, et al.
Published: (2008)

Oesophagectomy after definitive chemoradiation in patients with locally advanced oesophageal cancer.
by: Borghesi, S, et al.
Published: (2008)

Possibilities of palliative chemotherapy in patients with locally advanced and metastatic pancreatic cancer
by: L. I. Moskvicheva, et al.
Published: (2020-12-01)

653 Neoadjuvant CAN-2409+Prodrug plus chemoradiation for borderline resectable or locally advanced non-metastatic pancreatic adenocarcinoma (PDAC)
by: Francesca Barone, et al.
Published: (2023-11-01)

No More Venous Ulcers—What More Can We Do?
by: Agata Stanek, et al.
Published: (2023-09-01)

Do we see more than we can access?
by: Siegel, Susanna, et al.
Published: (2010)

Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer
by: Mengjiao Fan, et al.
Published: (2024-01-01)

miR-21 expression and clinical outcome in locally advanced pancreatic cancer: exploratory analysis of the pancreatic cancer erbitux, radiotherapy and UFT (PERU) trial.
by: Khan, K, et al.
Published: (2016)

The Advancement to the Circular Economy. Where We Are and What We Can Do at Local/Regional Level
by: Angela ALBU
Published: (2023-06-01)

Mother's milk: What more can we do?
by: Giuseppe Buonocore
Published: (2024-03-01)

Low vision: we can all do more
by: Hasan Minto, et al.
Published: (2012-01-01)

Nomogram to predict survival of patients with advanced and metastatic pancreatic Cancer
by: G. C. Deng, et al.
Published: (2021-11-01)

Biomarkers in metastatic melanoma of the skin: can we more accurately choose the tactics of treating our patients?
by: A. R. Zaretsky, et al.
Published: (2021-08-01)

Can we do more to get patients to cholesterol targets?
by: Hobbs, R
Published: (2002)

SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
by: Virdee, P, et al.
Published: (2017)

Metastatic Pancreatic Cancer
by: Piotr Hogendorf, et al.
Published: (2018-03-01)

On-going technical advances, can we use them to deliver more personalised medicine?
by: Simon de Lusignan
Published: (2011-05-01)

Inclusion at University: Can we do more than open the door?
by: John O'Rourke
Published: (2011-11-01)

THE POSSIBILITIES OF MODERN METHODS OF ABLATION IN NON-RESECTABLE LOCALLY ADVANCED PANCREATIC CANCER
by: L. I. Moskvicheva, et al.
Published: (2018-06-01)

Treatment of locally advanced and metastatic bladder cancer
by: Makarand V Khochikar
Published: (2008-01-01)

Treatment of Pancreatic Cancer: What Can We Really Predict Today?
by: Jean-Baptiste Bachet, et al.
Published: (2011-02-01)

We are more than others can say
by: David Steare
Published: (2022-04-01)

Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies
by: Anthony Turpin, et al.
Published: (2022-09-01)

P-233: SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
by: Virdee, P, et al.
Published: (2017)

A meta-analysis of gemcitabine containing chemotherapy for locally advanced and metastatic pancreatic adenocarcinoma
by: Ma Yue, et al.
Published: (2011-03-01)

Is remnant pancreatic cancer after pancreatic resection more frequent in early‐stage pancreatic cancer than in advanced‐stage cancer?
by: Yoshihiro Miyasaka, et al.
Published: (2020-07-01)

Systematic review of the clinical effectiveness and cost-effectiveness of capecitabine (Xeloda®) for locally advanced and/or metastatic breast cancer
by: L Jones, et al.
Published: (2004-02-01)

Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
by: Holyoake, DLP, et al.
Published: (2018)

Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
by: J Greenhalgh, et al.
Published: (2010-10-01)

Why do we know so little about refugees? How can we learn more?
by: Jeff Crisp
Published: (2003-09-01)

Smoking in children's playgrounds: Can we do more to protect our children?
by: José Precioso, et al.
Published: (2024-02-01)

Recurrent respiratory infection protection in children: can we do anything more?
by: article Editorial
Published: (2020-03-01)

Cisplatin and vinorelbine in the treatment of locally advanced and metastatic non-small cell lung cancer
by: Wong, Catherine Mee Ming, et al.
Published: (2001)

Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients
by: Alessandro Bittoni, et al.
Published: (2021-09-01)

Efficacy and safety of gemcitabine plus erlotinib for locally advanced or metastatic pancreatic cancer: a systematic review and meta-analysis
by: Wang Y, et al.
Published: (2016-06-01)

First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis
by: Zhang S, et al.
Published: (2018-11-01)